
EU Approves Enhertu Combo for First-Line HER2+ Breast Cancer
The European Commission approved Enhertu with pertuzumab as first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.
Umnagumo Plastic Surgery
Coverage of implant revision, reconstruction, and breast-surgery safety, with clinic facts verified against Umnagumo Plastic Surgery's official website.
External links are provided to verify the clinic's own information. A profile does not imply partnership, endorsement, or article review.
These clinicians are listed on the clinic's official website. Unless explicitly stated, they did not write or clinically review MediIndex articles.

The European Commission approved Enhertu with pertuzumab as first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.

Two sisters in their 30s were diagnosed with breast cancer six weeks apart after each found a breast lump.

A Yonsei Cancer Center team found that RAD51D-mutated breast cancer showed aggressive features but responded strongly to chemotherapy before surgery, suggesting a potential treatment-response marker.

Korean breast specialist societies issued guidance on when vacuum-assisted excision, commonly known as Mammotome, fits a particular patient.

A joint team at Korea’s National Cancer Center and UNIST identified the mitochondrial protein TRAP1 as the factor that turns normal fat cells into cancer-associated adipocytes.
When to Decide on Breast Revision — 26 reader questions, each answered in full with the caveats that matter.
Capsular Contracture: Causes and Grades — 26 reader questions, each answered in full with the caveats that matter.
Revision Consults and Imaging — 26 reader questions, each answered in full with the caveats that matter.
Recovering From Breast Revision — 26 reader questions, each answered in full with the caveats that matter.
After Explant: What the Breast Looks Like — 26 reader questions, each answered in full with the caveats that matter.
Breast Reconstruction Options — 26 reader questions, each answered in full with the caveats that matter.
Scar tissue forms around every breast implant as a normal part of healing — here’s what that capsule does, and the point at which a routine response can turn into a problem.

Every implant is wrapped in scar tissue — here is what happens when that capsule contracts, and how surgeons decide between watching and revising.
A vacuum-assisted device can remove many benign breast lumps through a skin opening a few millimeters wide — here is how the procedure works and where its limits lie.
A rare condition linked mainly to certain implant surfaces has raised understandable questions — here’s a calm look at what is known and how doctors approach monitoring.
Reconstruction can begin on the operating table with mastectomy or months to years later — the timing is a medical decision as much as a personal one.
Deciding to take breast implants out opens a second question — whether to remove them only, exchange them, or remove them and lift the breast — and each path asks something different of the tissue.

Cohesive silicone implants can rupture without symptoms — imaging is how these failures are found, and how replacement decisions get made.
Flap reconstruction rebuilds a breast from the patient’s own skin and fat — a longer operation with a different set of trade-offs from an implant.
After a breast surgery that didn’t turn out as hoped, the instinct is to fix it quickly — yet surgeons often counsel waiting, because tissue that is still healing tells an unreliable story.
Between mastectomy and a final implant often comes a months-long middle chapter — regular saline fills that stretch skin and muscle a little at a time.
When an implant’s edges show or ripple through thin tissue, transferring a patient’s own fat over the top can soften the contour — a supporting move in revision rather than a replacement for it.

Breast reconstruction after cancer surgery follows two broad paths — implant-based and autologous — each with its own timeline, trade-offs and recovery.
Every breast implant has a serial number, a registry entry and a manufacturer program behind it — paperwork that matters most years after surgery.
A soft bulge near the armpit is often not fat but accessory breast tissue — a common developmental leftover — and understanding it helps explain the options for smoothing it away.

Not every implant problem is a rupture — visible wrinkling and implants that drift out of position are among the most common reasons revision surgery is discussed.
In oncoplastic surgery, a breast surgeon and a plastic surgeon plan one operation together — cancer control first, shape considered from the start.